Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue

AIMS: Understanding the molecular mechanisms of underlying disease has led to a movement away from the one-drug-fits-all paradigm towards treatment tailored to the genetic profile of the patient. The Biocartis Idylla platform is a novel fully automated, real-time PCR–based in vitro diagnostic system...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, Louise, Power, Michael, Sloan, Philip, Long, Anna, Silmon, Angela, Chaffey, Ben, Lisgo, Andrea Jane, Little, Liam, Vercauteren, Ellen, Steiniche, Torben, Meyer, Tine, Simpson, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868529/
https://www.ncbi.nlm.nih.gov/pubmed/28899979
http://dx.doi.org/10.1136/jclinpath-2017-204629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868529/
https://www.ncbi.nlm.nih.gov/pubmed/28899979
http://dx.doi.org/10.1136/jclinpath-2017-204629

Ejemplares similares